STAAR's hyperopic ICLs (implantable contact lenses) enter Phase III trials:
This article was originally published in Clinica
Executive Summary
STAAR Surgical is to begin Phase III trials of its implantable contact lenses for farsightedness. The expanded US study will include patients with hyperopia of 1.5 dioptres and will reduce the waiting time for implanting the second ICL in the same from six months to 45 days.